Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2025 –2032 | |
|
|
USD 17.55 Billion |
| USD 90.16 Billion | |
| % | |
|
Global Synthetic Biology Market Segmentation, By Tool (Oligonucleotides and Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Chassis Organisms, Xeno-Nucleic Acids), Technology (Gene Synthesis, Genome Engineering, Sequencing, Bioinformatics, Cloning, Site-Directed Mutagenesis, Measurement and Modeling, Microfluids, Nanotechnology), Application (Medical Applications, Industrial Applications, Food and Agriculture, Environmental Applications), Products (Synthetic DNA, Synthetic Oligos, Synthetic Genes, Software Tools, Chassis Organisms, Synthetic Clones, Synthetic Cells) – Industry Trends and Forecast to 2032
Synthetic biology is an environmentally benign technology that has gained appeal for hazardous clean-up projects including synthetic microbes to digest refractory substances such as dioxins, insecticides, and even radioactive materials. Synthetic biology aids in the stabilisation of price growth in the medical industry, which drives up demand for this market. DNA synthesis technology and clustered regularly interspaced short palindromic repeats approaches have helped to lower the incidence of chronic diseases like cancer and diabetes. Biomedical, pharmaceutical, agricultural, biofuel, and chemical industries are all key users of this technology. Farmers can grow more crops on less area with synthetic biology, and it delivers more accuracy and perfection than prior gene technologies.
Global synthetic biology market size was valued at USD 17.55 billion in 2024 and is projected to reach USD 90.16 billion by 2032, with a CAGR of 22.70% during the forecast period of 2025 to 2032.
Report Scope and Market Segmentation
|
Attributes
|
Synthetic Biology Key Market Insights
|
|
Segmentation
|
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Key Market Players
|
Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Agilent Technologies, Inc. (U.S), Novozymes (Denmark), Ginkgo Bioworks (U.S.), Amyris (U.S.), Precigen Inc. (U.S.), GenScript (China), Twist Bioscience (U.S), Synthetic Genomics (U.S.), Codexis Inc. (U.S.), Synthego (U.S.), Creative Enzymes (U.S.), Eurofins Scientific (Luxembourg), Cyrus Biotechnology Inc. (U.S.), ATUM (U.S.), TeselaGen (U.S), Arzeda (U.S.), Integrated DNA Technologies Inc. (U.S.), New England Biolabs (U.S.)
|
|
Market Opportunities
|
|
Synthetic Biology Market Definition
Synthetic biology combines engineering and science to create unique biological systems with practical applications. Synthetic biology is the process of creating new biological units such as cells, enzymes, and genetic circuits and modifying existing biological systems. Synthetic biology's primary goal is to create new biological components that do not exist in nature, such as advanced biofuels, renewable chemicals, and bio goods. Synthetic biology discovers standardised genomic units that can be utilised to quickly synthesize and assemble small genomic parts into integrated large systems to tackle specific biological difficulties for the development of biological systems.
Synthetic Biology Market Dynamics
Drivers
The market is predicted to expand as demand for protein therapies and personalised medicine grows and research into synthetic pharmaceuticals and vaccines. Other factors such as increased synthetic biology application, increased synthetic biology investment, lower DNA sequencing and synthesising costs, and increased R&D expenditure and activities are likely to accelerate synthetic biology market expansion during the forecast period of 2025 to 2032.
R&D spending in the life sciences industry climbed by 22% from 2018 to 2019, according to a Business Wire report published in September 2020. Pharmaceutical companies have received more funds for research and development in order to discover new therapies. The government has made steps to fund various pharmaceutical and biotech enterprises in order to advance pharmaceutically and boost international competitiveness. As a result, R&D spending and funding have steadily rised throughout the years. Pharmaceutical and biotechnology businesses devote significant resources to research in order to create game-changing compounds that will meet the expanding demands of the healthcare industry and tackle emerging ailments. Pharmaceutical research and development accounts for more than 80% of all R&D spending in the life sciences industry.
Synthetic biology is used in the healthcare industry because it can help improve diagnostics and offer better treatment options for a variety of diseases by targeting only the disease site and creating no side effects. In addition, the use of genetically designed viruses to fix damaged genes in patients with inherited disorders such as epidermolysis bullosa or severe combined immune deficiency (SCID) has increased significantly. Aside from that, technologies for executing synthetic biology are becoming more accessible, and internet usage has facilitated free interchange of ideas and information, encouraging market expansion. Furthermore, the market is being influenced positively by significant expansion in the healthcare sector and an increase in the number of synthetic biology research units around the world.
Opportunities
Biofuels are becoming increasingly important as fuel use rises and concerns about energy security develop. Annually, nearly 150 billion tonnes of biomass are produced worldwide. Biofuels are currently made from edible commodities such as maize, sugarcane, and vegetable oil. As a result, synthetic biology techniques are becoming more widely used in renewable energy development.
Restraints/Challenges
The purposeful or unintentional release of synthetic organisms into the environment during research and other purposes is the primary biosafety risk in synthetic biology. When synthetic microorganisms are released into the environment, they might mutate or interact with existing organisms, potentially causing crossbreeding and bio errors. These repercussions may pose a hazard to natural creatures' ecosystems. Additionally, the emergence of antibiotic-resistant superbugs is a huge biosecurity risk. In recent years, the European Union (EU) has supported a number of studies into the environmental impact of genetically altered bacteria released for plant growth or bioremediation. These factors may limit the market's growth in the following years.
This synthetic biology market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the synthetic biology market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
The synthetic biology market is segmented on the basis of tool, technology and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Tool
Technology
Application
The synthetic biology market is analyzed and market size insights and trends are provided by country, tool, technology and application as referenced above.
The countries covered in the synthetic biology market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominating the synthetic biology market, due to various factors such as the increase in the number of well-established synthetic biology companies and research institutes in the US and Canada.
Asia-Pacific is expected to grow the synthetic biology market in the forecast period of 2025 to 2032 due to the growing number of pharmaceutical and biopharmaceutical companies and increasing healthcare and life science facilities which is expected to improve the synthetic biology market in forecast period.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
The synthetic biology market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to synthetic biology market.
Synthetic Biology Market Leaders Operating in the Market Are:
SKU-
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.